Evaluation of children with endocrine and metabolic conditions
Evaluation of Children With Endocrine and Metabolic-Related Conditions
This study is testing how endocrine and metabolic disorders affect children from 3 months to 18 years old by looking at their medical history and physical exams, and it may involve family members in genetic testing to help with diagnosis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 3 Months to 100 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT02769975 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate children aged 3 months to 18 years who have known or suspected endocrine or metabolic disorders. Researchers will conduct comprehensive assessments, including medical history reviews and physical exams, to understand the inheritance and progression of these conditions. Family members may also participate in genetic testing to aid in diagnosis. The study will track the natural development of these disorders in a diverse pediatric population.
Who should consider this trial
Good fit: Ideal candidates include children aged 3 months to 18 years with known or suspected endocrine or metabolic disorders.
Not a fit: Patients without suspected endocrine disorders or those with severe medical conditions that could complicate participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for children with endocrine and metabolic disorders.
How similar studies have performed: Other studies focusing on genetic and endocrine evaluations in pediatric populations have shown promise, indicating that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Participants with known or suspected endocrine disorder age 3 months-18 years are eligible for this protocol. * Relatives ages 3 months-100 years may be enrolled if clinically indicated for the diagnosis of a proband. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Lack of suspected endocrine disorders. * Any medical, physical, psychiatric, or social conditions, which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient, will exclude participation. Patients who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on Clinical Center or NICHD resources will be excluded.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Catherine M Gordon, M.D. — Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study coordinator: Harinder D Raipuria, C.R.N.P.
- Email: harinder.raipuria@nih.gov
- Phone: (301) 254-2982
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.